跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 91,691 条关于
“metastatic gastric cancers”
全部
91,691
临床试验
79,278
药物
1,671
机构
295
资讯
10,447
去年
I-Mab Prioritizes Givastomig for Gastric Cancer Treatment, Pauses Uliledlimab Development
去年
I-Mab Raises $65 Million to Advance Givastomig Phase 2 Trial for Gastric Cancer
去年
Everest Medicines Invests $30.9M in I-Mab Following Promising 83% Response Rate for Gastric Cancer Bispecific Antibody
去年
Prestige BioPharma's Tuznue Receives European Commission Approval as Herceptin Biosimilar
去年
Elevation Oncology's EO-3021 Shows Promise in Gastric and GEJ Cancers
去年
I-Mab Acquires Bridge Health Biotech to Strengthen Givastomig Bispecific Antibody Development
去年
FDA Approves New Dosage of Trastuzumab Biosimilar, First CLDN18.2-Targeted Therapy, and Delays Sotorasib Decision
去年
I-Mab Strengthens Leadership Team with Three New Board Appointments and R&D Committee Formation
去年
FDA Approves Astellas' Vyloy (Zolbetuximab) for Advanced Gastric and GEJ Adenocarcinoma
去年
Advancements in Targeted Therapy Refine Treatment Strategies for Gastric and GEJ Cancers
第 1 页，共 1045 页
上一页
下一页
